Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine–based immunosuppressive regimen: incidence, risk factors, progression, and prognosis1-Reference-Cited by-同舟云学术

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine–based immunosuppressive regimen: incidence, risk factors, progression, and prognosis1

Published:2003-07-27 Issue:2 Volume:76 Page:375-382
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Chueh Shih-Chieh J.,Kahan Barry D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Hyperlipidemia after organ transplantation;Markell;Am J Med,1989

2. Impact of serum lipids on long-term graft and patient survival after renal transplantation;Bumgardner;Transplantation,1995

3. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia;Hricik;Am J Kidney Dis,1991

4. Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients;Hoogeveen;Transplantation,2001

5. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study;Kahan;Lancet,2000

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus-Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case Report;Transplantation Proceedings;2022-01

2. Management of dyslipidemia in adult solid organ transplant recipients;Journal of Clinical Lipidology;2019-03

3. Post-transplant diabetes: diagnosis and management;Minerva Endocrinology;2018-04

4. From rapalogs to anti-aging formula;Oncotarget;2017-05-22

5. Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease;Journal of Clinical Lipidology;2017-01